The ImmunoPro project, led by world-leading Royal Brisbane and Women’s Hospital (RBWH) researchers, aims to develop a therapeutic vaccine tailored to each prostate cancer patient. The therapeutic vaccine would use immunotherapy post-prostatectomy to enhance and increase the patient’s own cancer-fighting cells.
This therapy has the potential to be extended to men in other advanced stages of prostate cancer, such as after initial radiotherapy, reducing the need for radiation and hormone therapy.
To #DonateForProstate please visit [ Ссылка ].
Check out more of RBWH Foundation here:
Website: www.rbwhfoundation.com.au
Facebook: www.facebook.com/RBWHFoundation
Instagram: www.instagram.com/rbwhf
LinkedIn: www.linkedin.com/company/1234781
Twitter: twitter.com/RBWHFoundation
RBWH Foundation saves lives through the extraordinary power of giving. Together, we advance life-saving research and patient care nationally and internationally.
